-
Does Testosterone Salvage PDE5i Non-Responders?
-
Evaluation of Adult Height in Patients with Non-Permanent Idiopathic GH Deficiency
-
Deleting Cellular Retinoic-Acid-Binding Protein-1 (Crabp1) Gene Causes Adult-Onset Primary Hypothyroidism in Mice
-
The Impact of COVID-19 Regulations on Adherence to Recombinant Human Growth Hormone Therapy: Evidence from Real-World Data
-
Parathyroid Carcinoma: News on Pathogenesis and Therapy
Journal Description
Endocrines
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within CAPlus / SciFinder, and other databases.
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 27.5 days after submission; acceptance to publication is undertaken in 5.8 days (median values for papers published in this journal in the second half of 2022).
- Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Latest Articles
E-Mail Alert
News
Topics
Deadline: 30 June 2023
Deadline: 8 July 2023
Deadline: 20 November 2023
Conferences
Special Issues
Deadline: 10 August 2023
Deadline: 15 August 2023
Deadline: 15 September 2023
Deadline: 15 December 2023